FOMX - Foamix Pharmaceuticals EPS beats by $0.05 November, 11 2019 06:09 AM Foamix Pharmaceuticals Ltd. Foamix Pharmaceuticals (NASDAQ:FOMX): Q3 GAAP EPS of -$0.41 beats by $0.05.Cash and cash equivalents of $40.53MPress ReleaseMore news on: Foamix Pharmaceuticals Ltd., Earnings news and commentary, Healthcare stocks news,